To determine the presence and amount of igm monoclonal proteins, an additional test called serum protein electrophoresis spep will be performed. How i treat waldenstrom macroglobulinemia blood american. The genomic landscape of waldenstrom macroglobulinemia is characterized by highly recurring myd88 and whimlike cxcr4 mutations, and small somatic deletions associated with bcell lymphomagenesis. Bendamustine, bortezomib, carfilzomib and cyclophosphamide are highly effective when combined with rituximab. How we manage patients with waldenstrom macroglobulinaemia. Mar 30, 2016 if you have problems viewing pdf files, download the latest version of adobe reader for language access assistance, contact the ncats public information officer genetic and rare diseases information center gard po box 8126, gaithersburg, md 208988126 tollfree. The 2018 esmo clinical practice guidelines on waldenstroms macroglobulinemia wm are based on results from recent studies and updated analyses. Waldenstrom macroglobulinemia genetic and rare diseases. The diagnosis of wm requires a bone marrow bm biopsy showing infiltration by clonal lymphoplasmacytic cellslymphoplasmacytic lymphoma lpl and the presence of any amount of monoclonal igm, 5,6 detected by immunofixation electrophoresis. If the patient had any abnormality other than del 6q. Waldenstrom macroglobulinemia and multiple myeloma are mature bcell neoplasms deriving from postgerminal cells at. Successful outcome in waldenstroms macroglobulinemia treated. San miguel1,2 abstract little is known about the dna cell content and cell cycle characteristics of immunoglobulin ig m monoclonal gammopathies.
Waldenstrom macroglobulinemia wm is an uncommon lymphoma. In some patients, the monoclonal protein will lead to a characteristic hyperviscosity syndrome. There is no threshold for bm clonal cell infiltration, but individuals with less than 10% clonal cells have an indolent course 7 compared with. Waldenstrom macroglobulinemia wm is a lymphoid neoplasm characterised by a monoclonal lymphoplasmacytic expansion accompanied by a serum monoclonal immunoglobulin m igm. Waldenstrom macroglobulinemia american cancer society. Pdf waldenstroms macroglobulinemia wm is a lymphoproliferative disease of b lymphocytes, characterized by a lymphoplasmocytic. In this how i treat article on waldenstrom macroglobulinemia, the.
Waldenstrom macroglobulinemia millennium medical publishing. Highdose therapy and autologous stemcell transplantation in waldenstrom macroglobulinemia. Waldenstrom macroglobulinemia, which is an indolent slowgrowing bcell lymphoma, is a type of lymphoplasmacytic lymphoma. Although indolent, wm is incurable and most patients eventually succumb to disease progression. Waldenstrom macroglobulinemia symptoms and causes mayo clinic. C, serum protein electrophoresis mspike monoclonal gammopathy, arrow.
Both igm and m protein, measured by serum protein electrophor. Predispositions and origins of waldenstrom macroglobulinemia. Sometimes, waldenstrom macroglobulinemia wm isnt causing any symptoms when its first found. Waldenstrom macroglobulinemia wm is a slowgrowing, rare type of nonhodgkin lymphoma, which is a blood cancer. Frontline treatment options in waldenstrom macroglobulinemia.
Signs and symptoms of waldenstrom macroglobulinemia what patients and caregivers need to know about cancer, coronavirus, and covid19. Waldenstrom s macroglobulinemia waldenstroms macroglobulinemia is a rare disease entity, inclosed within the boundaries of. The most common known genetic change associated with this condition is a mutation in the myd88 gene, which is found in more than 90 percent of affected individuals. Presence of igm monoclonal protein associated with.
Clinical features include anemia, thrombocytopenia, hepatosplenomegaly, lymphadenopathy, and rarely hyperviscosity. There are about 5,000 new cases of waldenstrom macroglobulinemia diagnosed each year in the united states. Waldenstroms macroglobulinemia wm is a lymphoproliferative disease of b. Entre aquests, 11 es van dur a terme en pacients no tractats previament, 14 en pacients amb waldenstrom refractari o recaigut. Exciting clinical trials with oral agents are ongoing. The most consistent feature of the bone marrow or lymph nodes of patients with wm is the presence of pleomorphic blineage cells at different stages of maturation, such as small lymphocytes, lymphoplasmacytoid cells abundant basophilic cytoplasm but lymphocytelike nuclei, and plasma. Wm is a malignant lymphoplasmoproliferative disorder with monoclonal pentameric igm production. Wm is a type of cancer affecting two types of b cells. Waldenstrom macroglobulinemia wm is a lymphoplasmacytic. Both igm and m protein, measured by serum protein electrophoresis, correlate well with. Bcells normally mature into plasma cells whose job is to produce immunoglobulins antibodies to help the body fight infections.
Although wm remains to be an incurable disease with a heterogeneous clinical course, the. Waldenstroms macroglobulinemia lymphoplasmacytic lymphoma mac. Waldenstrom macroglobulinemia wm is a lowgrade bcell clonal disorder characterized by lymphoplasmacytic bone marrow involvement associated with monoclonal immunoglobulin m. A sursyvlwr gh xq fdvr luis g ramonrodriguez, gelquin musteliercelza, onel avilacabrera, leslie gonzalezpinedo, adys gutierrezdiaz, carlos hernandez. Future treatments are likely to be less toxic and more effective. Bortezomib, fludarabine, thalidomide, everolimus, ibrutinib, carfilzomib, lenalidomide, and bendamustine have all been shown to have activity in relapsed wm. Here you can find out all about waldenstrom macroglobulinemia, including risk factors, symptoms, how it is found, and how it is treated. Wm is characterized by having high levels of a circulating antibody, immunoglobulin m igm, which is made and secreted by the cells. The most consistent feature of the bone marrow or lymph nodes of patients with wm is the presence of pleomorphic blineage cells at different stages of maturation, such as small lymphocytes, lymphoplasmacytoid cells abundant basophilic cytoplasm but lymphocytelike nuclei, and plasma cells. It is rare, representing approximately one percent of all nonhodgkin lymphomas nhls. Wm is considered to be an indolent slow growing lymphoma and it is primarily found in the bone marrow although lymph nodes.
Waldenstroms macroglobulinemia wm lymphoma australia. It usually affects older adults and is primarily found in the bone. What is the pathophysiology of waldenstrom macroglobulinemia. Altered morphology of serum protein electrophoresis. Waldenstrom macroglobulinemia blood american society of. Understanding waldenstrom macroglobulinemia lymphoma. Wm cells have features of both blymphocytes and plasma cells lymphoplasmacytic. Signs and symptoms of waldenstrom macroglobulinemia. It occurs in a type of white blood cell called a blymphocyte or bcell.
Pdf cell cycle analysis of waldenstroms macroglobulinemia. Given wms natural history, reduction of therapy toxicity is an important part of treatment selection. Electrophoresis of serum proteins, detection of monoclonal gammopathy. Waldenstrom macroglobulinaemia the lancet oncology. Waldenstrom s macroglobulinemia wm fact sheet pdf overview of waldenstrom s macroglobulinemia wm waldenstrom s macroglobulinemia wm is a rare subtype of bcell lymphoma, making up 1 to 2 percent of all nonhodgkin lymphoma nhl cases. Mar 28, 2021 the genomic landscape of waldenstrom macroglobulinemia is characterized by highly recurring myd88 and whimlike cxcr4 mutations, and small somatic deletions associated with bcell lymphomagenesis. Although wm remains to be an incurable disease with a heterogeneous clinical course, the recent discovery of mutations in the myd88 and cxcr4 genes further enhanced our.
1552 499 1097 1204 1267 1542 1068 596 1407 433 825 411 418 1458 668 213 334 286 46 1470 718 845 1154 438 1240 744 1486 426 1647 983 43 741 903 873 440 761 1379